A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00140933|
Recruitment Status : Terminated
First Posted : September 1, 2005
Last Update Posted : December 5, 2006
|Condition or disease||Intervention/treatment||Phase|
|Pain||Drug: MK0966; rofecoxib Drug: Comparator: diclofenac, placebo||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||274 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Randomized, Double-Blind, 7-Day Study of the Efficacy and Safety of Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome|
|Study Start Date :||April 2003|
- Pain during daily activities assessed by a Numerical Rating Score (NRS)
- Functional impairment evaluated using Neer's functional index.
- Global assessment of disease activity by the patient with a NRS.
- Intensity of night pain evaluated by NRS.
- Rescue treatment take during the study duration.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00140933
|Laboratoires Merck Sharp & Dohme - Chibret|
|Paris Cedex 8, France, 75114|
|Study Director:||Medical Monitor||Merck Sharp & Dohme Corp.|